We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+8.94%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$76.2B
AUM Growth
+$2.6B
Cap. Flow
-$2.97B
Cap. Flow %
-3.9%
Top 10 Hldgs %
21.61%
Holding
3,238
New
235
Increased
684
Reduced
2,065
Closed
243

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$77.3M
2
BX icon
Blackstone
BX
+$53.2M
3
NXPI icon
NXP Semiconductors
NXPI
+$40.8M
4
PLTR icon
Palantir
PLTR
+$34.3M
5
SNOW icon
Snowflake
SNOW
+$24.8M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$206M
2
MSFT icon
Microsoft
MSFT
+$163M
3
LIN icon
Linde
LIN
+$133M
4
AMZN icon
Amazon
AMZN
+$94.7M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$82.6M

Sector Composition

Rank Sector Weight
1 Technology 23.34%
2 Financials 14.16%
3 Healthcare 12.95%
4 Consumer Discretionary 12.06%
5 Communication Services 9.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTSO icon
2776
Cytosorbents Corp
CTSO
$25M
$305K ﹤0.01%
40,427
-2,131
-5% -$18K
HRTG icon
2777
Heritage Insurance Holdings
HRTG
$1.07B
$305K ﹤0.01%
35,547
-3,188
-8% -$29.4K
PSTX
2778
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$305K ﹤0.01%
30,461
+8,301
+37% +$74.3K
TAST
2779
DELISTED
Carrols Restaurant Group, Inc.
TAST
$305K ﹤0.01%
50,708
-7,538
-13% -$44.5K
HBMD
2780
DELISTED
Howard Bancorp, Inc. Common Stock
HBMD
$305K ﹤0.01%
18,911
-2,093
-10% -$34.6K
IHC
2781
DELISTED
Independence Holding Company
IHC
$305K ﹤0.01%
6,576
-1,431
-18% -$63.5K
CRDF icon
2782
Cardiff Oncology
CRDF
$74.7M
$304K ﹤0.01%
+45,690
New +$388K
FBRX icon
2783
Forte Biosciences
FBRX
$1.57B
$303K ﹤0.01%
+360
New +$324K
AEVA
2784
Aeva Technologies
AEVA
$1.73B
$302K ﹤0.01%
+5,721
New +$289K
FRBA icon
2785
First Bank
FRBA
$458M
$302K ﹤0.01%
22,334
-3,606
-14% -$46.7K
ONEW icon
2786
OneWater Marine
ONEW
$199M
$302K ﹤0.01%
7,194
+244
+4% +$11.3K
ONCR
2787
DELISTED
Oncorus, Inc.
ONCR
$301K ﹤0.01%
+21,792
New +$337K
SCWX
2788
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
$300K ﹤0.01%
16,174
-1,522
-9% -$23.7K
USX
2789
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
$300K ﹤0.01%
34,928
-1,435
-4% -$15.3K
UWMC icon
2790
UWM Holdings
UWMC
$407M
$296K ﹤0.01%
+35,044
New +$293K
CRMD icon
2791
CorMedix
CRMD
$589M
$295K ﹤0.01%
43,039
+18,488
+75% +$147K
FDBC icon
2792
Fidelity D&D Bancorp
FDBC
$313M
$295K ﹤0.01%
5,452
-473
-8% -$26.4K
AQB icon
2793
AquaBounty Technologies
AQB
$5.51M
$294K ﹤0.01%
+2,741
New +$315K
GCMG icon
2794
GCM Grosvenor
GCMG
$814M
$294K ﹤0.01%
+28,193
New +$333K
REKR icon
2795
Rekor Systems
REKR
$89M
$294K ﹤0.01%
+28,985
New +$444K
AMAL icon
2796
Amalgamated Financial
AMAL
$1.5B
$293K ﹤0.01%
18,767
-1,725
-8% -$27.9K
BELFB
2797
Bel Fuse Inc Class B
BELFB
$4.18B
$292K ﹤0.01%
20,284
-15,354
-43% -$253K
IEA
2798
DELISTED
Infrastructure and Energy Alternatives, Inc. Common Stock
IEA
$292K ﹤0.01%
+22,687
New +$284K
BCEL
2799
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$291K ﹤0.01%
34,125
+6,190
+22% +$63.4K
HMTV
2800
DELISTED
Hemisphere Media Group, Inc.
HMTV
$291K ﹤0.01%
24,642
-2,596
-10% -$32.2K

Similar funds

RhumbLine Advisers's Q2 2021 Portfolio in Review

As of Q2 2021, RhumbLine Advisers held 3,238 positions worth $76.2B, up 3.5% from $73.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

RhumbLine Advisers withdrew a net $2.97B in Q2 2021, closing 243 positions and reducing 2,065 holdings. Its most notable exit was Varian Medical Systems, Inc., an estimated $32.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

Against the trend, RhumbLine Advisers opened a new position in DraftKings worth $14.2M.

  • RhumbLine Advisers's largest Q2 2021 buy was DraftKings: 271,227 shares worth $14.2M.
  • RhumbLine Advisers added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $77.3M increase.
  • RhumbLine Advisers's biggest Q2 2021 reduction was Apple, cutting an estimated $206M.
  • RhumbLine Advisers fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $32.1M.
  • RhumbLine Advisers's ten largest holdings make up 22% of its $76.2B portfolio in Q2 2021.
  • RhumbLine Advisers opened 235 new positions and closed 243 in Q2 2021.
  • RhumbLine Advisers's portfolio value rose 3.5% quarter-over-quarter to $76.2B.

Based on RhumbLine Advisers's 13F filing for Q2 2021, filed 5 Aug 2021.